In effort to understand the effect of the COVID-19 pandemic among patients with sickle cell disease, researchers compared outcomes and characteristics of hospitalized patients both before and during the...
In their case-controlled study that utilized the National Inpatient Sample 2016-2019 database, researchers set out to examine the relationship between leukemia and sickle cell trait.
Individuals with acute myeloid leukemia often have low levels of vitamin C and vitamin D at the time of diagnosis. Researchers examined how supplementation of these vitamins during treatment impacted...
Researchers compared the effects of once-weekly semaglutide (2.4 mg) with a placebo during a 52-week period in patients with HFpEF and a BMI of 30 or higher.
This COVID-19 roundup includes coverage on the outcomes associated with two omicron subvariant treatments, FDA’s authorization of Novavax vaccine, the NIH Treatment Guidelines Panel’s recommendation of...
Researchers set out to determine whether DNA sequencing of the blood from adults with acute myeloid leukemia in remission before allogeneic hematopoietic cell transplant could detect residual variant...